lobbying_activities: 2510008

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2510008	d37db5a7-5167-4be5-9a98-180968b55c3e	Q3	POLSINELLI PC	314911	TEVA PHARMACEUTICALS USA, INC.	2020	third_quarter	PHA	S. 2543, Prescription Drug Pricing Reduction Act S. 1895, Lower Health Care Costs Act H.R. 3, Lower Drug Costs Now Act Coronavirus stimulus legislation Review of Administration drug pricing and telehealth policies H.R. 8337, Continuing Appropriations Act, 2021 and Other Extensions Act	HOUSE OF REPRESENTATIVES,SENATE	80000		0	0	2020-10-15T17:11:45.260000-04:00